Table 1.
Baseline clinical characteristics of patients.
| Characteristics | The entire cohort number = 80 | The train cohort number = 56 | The test cohort number = 24 | p-value |
|---|---|---|---|---|
| Age | 55.12 ± 12.23 | 55.62 ± 12.34 | 53.96 ± 12.16 | 0.58 |
| Height | 165.30 ± 7.87 | 164.89 ± 8.21 | 166.25 ± 7.08 | 0.528 |
| Weight | 64.94 ± 9.73 | 64.24 ± 8.93 | 66.58 ± 11.42 | 0.327 |
| BMI | 23.74 ± 3.02 | 23.65 ± 3.00 | 23.95 ± 3.12 | 0.683 |
| Tumor volume | 46.30 ± 37.04 | 40.52 ± 29.63 | 59.77 ± 48.39 | 0.076 |
| Tumor area | 1.96 ± 1.05 | 1.93 ± 1.06 | 2.04 ± 1.04 | 0.58 |
| Sex | 1.0 | |||
| Male | 42 (52.50) | 29 (51.79) | 13 (54.17) | |
| Female | 38 (47.50) | 27 (48.21) | 11 (45.83) | |
| Chronic | 0.493 | |||
| No | 43 (53.75) | 32 (57.14) | 11 (45.83) | |
| Yes | 37 (46.25) | 24 (42.86) | 13 (54.17) | |
| Family disease | 1.0 | |||
| No | 78 (97.50) | 55 (98.21) | 23 (95.83) | |
| Yes | 2 (2.50) | 1 (1.79) | 1 (4.17) | |
| Level | 0.035 | |||
| 3 | 25 (31.25) | 13 (23.21) | 12 (50.00) | |
| 4 | 55 (68.75) | 43 (76.79) | 12 (50.00) | |
| Pathological type | 0.015 | |||
| Glioblastoma | 53 (66.25) | 42 (75.00) | 11 (45.83) | |
| Astrocytoma | 10 (12.50) | 5 (8.93) | 5 (20.83) | |
| Oligodendroglioma | 11 (13.75) | 4 (7.14) | 7 (29.17) | |
| Other | 6 (7.50) | 5 (8.93) | 1 (4.17) | |
| Multifocal | 0.122 | |||
| No | 72 (90.00) | 48 (85.71) | 24 (100.00) | |
| Yes | 8 (10.00) | 8 (14.29) | Null | |
| Tumor location | 0.156 | |||
| Left | 35 (43.75) | 21 (37.50) | 14 (58.33) | |
| Right | 42 (52.50) | 32 (57.14) | 10 (41.67) | |
| Multi-area | 3 (3.75) | 3 (5.36) | Null | |
| Beyond midline | 0.367 | |||
| No | 49 (61.25) | 32 (57.14) | 17 (70.83) | |
| Yes | 31 (38.75) | 24 (42.86) | 7 (29.17) | |
| IDH | 0.45 | |||
| No | 50 (62.50) | 37 (66.07) | 13 (54.17) | |
| Yes | 30 (37.50) | 19 (33.93) | 11 (45.83) | |
| Necrosis | 0.054 | |||
| No | 26 (32.50) | 14 (25.00) | 12 (50.00) | |
| Yes | 54 (67.50) | 42 (75.00) | 12 (50.00) |